Retinai: Funding, Investors & Team (Sep 2026)
RetinAI is a Swiss & US-based software company improving and supporting R&D of first-in-human drug candidates, supercharging management and oversight of clinical trials and enabling the research needed to elevate the quality of care on patients with eye diseases. We achieve this goal by building tools to collect, analyze and to organize health data. Our fundamental belief is that in the future every patient will use drugs alongside a digital application that will enable them and their physicians to better assess the right drug, in the right amount and the right frequency for patients.
Retinai has raised $14.0M across 2 funding rounds on record, the most recent a Series B of $7.8M announced in Oct 2024.
That round is above the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Retinai Company Profile and Key Stats
Latest funding round on record: Oct 2024.
Retinai Funding Rounds
Retinai raised $6.2M in a Series A announced in May 2024.
5 months later, a Series B of $7.8M was announced in Oct 2024.
Retinai Founders and Leadership Team
Contact details for the Retinai team: 1 of 1 has an email address on file.
Start 14-day free trial →Retinai Funding Compared to Other Artificial Intelligence Startups
Retinai's latest round of $7.8M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Retinai in Artificial Intelligence and Bern
Companies Similar to Retinai
At SUIND, our goal is to utilize advanced technology to enhance the productivity and ecological impact of…
Established in 2018, Aktiia, now operating under the name Hilo, aims to revolutionize the measurement and…
Anyway Systems is an IT company that develops AI deployment software for organizations.
Rflect helps universities protect their business model in the age of AI by training the human skills machines…
Computer Vision develops artificial intelligence software for medical imaging with a focus on radiology and…
Expert in AI-generated multi-marker algorithms. First product launched (Software as Medical Device) to…
Hephaistos develops AI-based systems to design new enzymes from scratch for use in chemical and industrial…
AVIAN is an industrial AI business that creates temperature monitoring and predictive safety systems for…
Gravit Open Network is a distributed infrastructure for epistemic execution and verifiable knowledge. It…
Moonlight AI empowers pathologists and hematologists to make therapeutic decisions backed by genomic insight.…
Newborns’ sounds of cries carry a wealth of information about their health, needs and emotions – including…
KEMARO GmbH, headquartered in Eschlikon, Switzerland, was founded in August 2016 by three engineers…
Retinai Funding FAQs
What does Retinai do?
RetinAI is a Swiss & US-based software company improving and supporting R&D of first-in-human drug candidates, supercharging management and oversight of clinical trials and enabling the research needed to elevate the quality of care on patients with eye diseases. We achieve this goal by building tools to collect, analyze and to organize health data. Our fundamental belief is that in the future every patient will use drugs alongside a digital application that will enable them and their physicians to better assess the right drug, in the right amount and the right frequency for patients.
How much funding has Retinai raised?
Retinai has raised $14.0M across 2 rounds on record. The most recent is a Series B of $7.8M announced in Oct 2024.
When did Retinai last raise funding?
Retinai's most recent funding round on record is a Series B of $7.8M, announced in Oct 2024.
Who founded Retinai?
FundedIQ lists Carlos Ciller (Founder) at Retinai.
Where is Retinai headquartered?
Retinai is based in Bern, Switzerland.
How many employees does Retinai have?
Retinai is in the 11-50 employee band.
How does Retinai's funding compare to other Artificial Intelligence startups?
Retinai's latest round of $7.8M is above the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.
About FundedIQ's Retinai Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Retinai is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.